Use of prostate-specific membrane antigen positron-emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer
2018 ◽
Vol 1
(1)
◽
pp. 78-82
◽
2019 ◽
Vol 105
(1)
◽
pp. E572-E573